Home
Conditions
Mesothelioma, Malignant

Clinical trial condition

Mesothelioma, Malignant

Explore clinical trials studying Mesothelioma, Malignant. Study availability and eligibility vary by location and protocol.

225 public trials 44 recruiting studies

Refine in advanced search Browse all conditions

Mesothelioma, Malignant trial results

Completed

Immunotoxin Therapy in Treating Patients With Advanced Solid Tumors

NCT00066651

Conditions: Adenoma, Adnexal Diseases, Brenner Tumor, +60 more
Locations: Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States

Comprehensive Cancer Center at Wake Forest University Winston-Salem, North Carolina, United States

View Trial Details

Completed

Immunotoxin Therapy in Treating Patients With Advanced Cancer

NCT00006981

Conditions: Adenoma, Adnexal Diseases, Brenner Tumor, +60 more
Locations: Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States

View Trial Details

Completed

Decitabine in Treating Patients With Unresectable Lung or Esophageal Cancer or Malignant Mesothelioma of the Pleura

NCT00019825

Conditions: Adenoma, Bronchial Neoplasms, Carcinoma, Bronchogenic, +33 more
Locations: Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States

Center for Cancer Research Bethesda, Maryland, United States

View Trial Details

Completed

Pazopanib in Treating Patients With Malignant Pleural Mesothelioma

NCT00459862

Conditions: Adenoma, Advanced Malignant Mesothelioma, Localized Malignant Mesothelioma, +14 more
Locations: North Central Cancer Treatment Group Rochester, Minnesota, United States

View Trial Details

Completed

Phase II Study of Valproate and Doxorubicin in Malignant Mesothelioma

NCT00634205

Conditions: Adenoma, Lung Diseases, Lung Neoplasms, +12 more
Locations: Department of Pneumology CHR St joseph - Warquignies Boussu, Belgium

Department of Intensive Care Unit and Thoracic Oncology Institut Jules Bordet Brussels, Belgium

Department of Pneumology Hôpital Ixelles-Molière Brussels, Belgium

Department of Pneumology CHU Charleroi Charleroi, Belgium

View Trial Details

Completed

Bortezomib in Treating Patients With Malignant Pleural Mesothelioma

NCT00513877

Conditions: Adenoma, Lung Diseases, Lung Neoplasms, +12 more
Locations: Universitair Ziekenhuis Gent Ghent, Belgium

Cork University Hospital Cork, Ireland

Adelaide and Meath Hospital, Dublin Incorporating the National Children's Hospital Dublin, Ireland

St. Vincent's University Hospital Dublin, Ireland

View all 13 locations

View Trial Details

Completed

Molecular Predictors of Pemetrexed and Carboplatin Response in Malignant Pleural Mesothelioma (MPM) Patients

NCT00867711

Conditions: Adenoma, Lung Diseases, Lung Neoplasms, +12 more
Locations: Istituto Clinico Humanitas Rozzano, Milano, Italy

View Trial Details

Completed

Cediranib Maleate in Treating Patients With Malignant Mesothelioma That Cannot Be Removed By Surgery

NCT00309946

Conditions: Adenoma, Advanced Malignant Mesothelioma, Epithelial Mesothelioma, +21 more
Locations: University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States

View Trial Details

Completed

Sunitinib in Treating Patients With Advanced Malignant Pleural Mesothelioma

NCT00392444

Conditions: Adenoma, Advanced Malignant Mesothelioma, Lung Diseases, +13 more
Locations: National Cancer Institute of Canada Clinical Trials Group Kingston, Ontario, Canada

View Trial Details

Completed

Pleurectomy/Decortication Followed by Intrathoracic/Intraperitoneal Heated Cisplatin for Malignant Pleural Mesothelioma

NCT00165555

Conditions: Adenoma, Lung Diseases, Lung Neoplasms, +13 more
Locations: Brigham and Women's Hospital Boston, Massachusetts, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Mesothelioma, Malignant

Mesothelioma, Malignant trial results

Related conditions